Ximino
- Product NDC
- 10631-332
- 11-digit product format
- 106310332
- Labeler code
- 10631
- Product ID
- 10631-332_c87b3360-adb8-444e-9591-52d2b97b8e08
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- minocycline hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc
- Application
- NDA201922
- Marketing category
- NDA
- Marketing start
- 2017-10-25
- Marketing end
- 0000-00-00
- Substance
- MINOCYCLINE HYDROCHLORIDE
- Active strength
- 135 mg/1
- Pharmacologic classes
- Tetracycline-class Drug [EPC],Tetracyclines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 10631-332-05 | 2023-07-03 | C162847 | 48780-1 | 9d75b9d0-f991-f424-e053-dadaa90a57ce | 6e7d2a2f-e4b2-4d12-8d5d-e1c3a832b35c |
| 10631-332-30 | 2023-07-03 | C162847 | 48780-1 | 9d75b9d0-f991-f424-e053-dadaa90a57ce | 6e7d2a2f-e4b2-4d12-8d5d-e1c3a832b35c |
| 10631-332-69 | 2023-07-03 | C162847 | 48780-1 | 9d75b9d0-f991-f424-e053-dadaa90a57ce | 6e7d2a2f-e4b2-4d12-8d5d-e1c3a832b35c |
| 10631-332-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-f991-f424-e053-dadaa90a57ce | 6e7d2a2f-e4b2-4d12-8d5d-e1c3a832b35c |
| 10631-332-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-f991-f424-e053-dadaa90a57ce | 6e7d2a2f-e4b2-4d12-8d5d-e1c3a832b35c |
| 10631-332-69 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-f991-f424-e053-dadaa90a57ce | 6e7d2a2f-e4b2-4d12-8d5d-e1c3a832b35c |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 10631-332-30 | EA - Each | 10631-332 | 3da83f62-076c-4c4d-b05b-36d40babd5ef | 1 | 2017-11-06 |